跳至主要内容
临床试验/EUCTR2021-001028-16-ES
EUCTR2021-001028-16-ES进行中(未招募)1 期

DEXamethasone EARLY administration in hospitalized patients with Covid-19 pneumonia and high risk of developing acute respiratory distress syndrome - EARLY-DEX Covid-19

Fundación para la Investigación e Innovación Biomédica (FIIB) del Hospital Universitario Infanta Leonor y Hospital Unive0 个研究点目标入组 126 人开始时间: 2021年9月1日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
126

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Hospitalized patients with Covid-19 pneumonia who do not require oxygen therapy on admission associated with at least two of the three following factors related with severe Covid-19: lactate dehydrogenase > 245 U/L, C-reactive protein > 100 mg/L and lymphocyte count < 800 cells/µL.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 76
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 50

排除标准

  • Unconfirmed SARS-CoV-2 infection
  • Pregnant or breastfeeding women
  • Oral or inhaled corticosteroid therapy within 15 days before
  • Oral or inhaled corticosteroid therapy for chronic medical condition
  • Immunosuppressive therapy
  • Cytotoxic chemotherapy within 30 days before
  • Neutrophil count < 1000 cells/mm3 for hematologic malignancy or solid tumor
  • Dementia or psychosis
  • Human immunodeficiency virus infection
  • Patients with liver disease defined as ALT or AST = 5 times the upper limit of normal
  • Patients with kidney disease defined as glomerular filtration rate = 30 ml/min, hemodialysis or peritoneal dialysis
  • Uncontrolled bacterial infection

研究者

发起方
Fundación para la Investigación e Innovación Biomédica (FIIB) del Hospital Universitario Infanta Leonor y Hospital Unive

相似试验

DEXamethasone EARLY administration in hospitalized... | 临床试验